Laser Consult Ltd. posted this:Multifunctional Syringe (Protected Healthcare Workers)This is a medical device, is a syringe, which solves the problem of the danger of infecting patients and health care workers with diseases that can be transmitted by injecting with an already used needle. With this new syringe model, you can apply the drug enormously quickly while protecting yourself. It is intended for a single use with only one use practically possible. The dosage is much easier because it has two measuring scales. The volume is 15ml but can be changed as needed is it can be produced in different sizes. The disinfection mechanism is in the syringe, and one of the novelties is that the needle has no contact with the healthcare worker applying the therapy.
Covid-19 Innovation Challenges by Innoget posted this:Inhibitors of Viral Infectivity: Amphipathic Nucleoside Derivatives as Fusion InhibitorsA series of small pharmacological molecules have been discovered to be potent and non-cytotoxic inhibitors of viral fusion. The inhibitors act on the non-virally encoded lipids in the virion envelope. These molecules are rigid amphipathic compounds of inverted cone shape which locate to the outer leaflets of virion envelopes, creating a physical barrier to viral envelope and cell membrane fusion. These amphipathic nucleoside derivatives can serve as potential antiviral or therapeutic agents against herpes, HIV, influenza, hepatitis B & C, poxvirus and other DNA or RNA enveloped viruses. They can potentially be used as prophylactic ingredients in creams, lotions, gels and as antiviral disinfectants.
Ivan Rodriguez Rosello posted this:
Licensing Manager at Universidad de Alicante
David Guillén posted this:
Licensing Manager at CAMBIOTEC
Joshua D'Souza posted this:
Sales Engineer at MistyWest
Krasen Dimitrov posted this:
CEO at MAMEL&Ecobiotechnoservice
Research InstituteView Profile
Germans Trias i Pujol Health Sciences Research Institute posted this:Diagnostic biomarkers for dementia with Lewy BodiesThe present data provide a solid basis for the development of genetic biomarkers for the early identification of patients suffering from dementia with Lewy bodies and to classify them into specific molecular subtypes. One of the biomarkers correlates with the development of Lewy pathology in the brain and may be useful to monitor the success of possible alpha-synuclein antiaggregatory therapies.
Pragmatec posted this:Chitosan-based wound dressing for diabetic foot ulcer treatment and burn woundsChitosan-based wound dressing that stimulates the closure, neovascularization and permanent regeneration of dermis in diabetic feet’s ulcers. It reduces the risk of amputation in patients.This innovation can also be used to prevent or treat wound and burn infections, not only due to its intrinsic antimicrobial properties, but also due to its ability to deliver extrinsic antimicrobial agents to wounds and burns. Additionally, it can be used as a slow-release drug-delivery vehicle for growth factors to stimulate and improve wound healing. This technology offers a complete regeneration of the ulcer using a single copy of the material without the need for invasive treatment, ensuring no backsliding in the development of ulcers. The purification process triggered by the chitosan and the ensuing chemical modifications in the membranes reduce possible allergic reactions and maximize the benefits, such as its antibacterial effects.
Cracow University of Technology posted this:Suspension containing gold or silver nanoparticles or a mixture thereof and a production method thereofThe present invention relates to a process for the preparation of nanosilver and nanogold using an aqueous extract of dog rose, white grape and knotweed. Substances which were extracted from these plants act both as reducer of silver and gold ions and stabilizing agent of forming silver and gold nanodispersion, preventing them from agglomeration and inhibiting their growth, so that the resulting particle size does not exceed 100 nm.
RAMOT at Tel Aviv University Ltd. posted this:Surface Plasmon Amplification of stimulated emissionSurface Plasmon Amplification of stimulated emission Project ID : 11-2011-127
RAMOT at Tel Aviv University Ltd. posted this:Low energy laser bio-stimulation of bone marrow stem cells for the treatment of myocardial infarctionHeart diseases are the leading cause of death worldwide. Low energy laser (light) irradiation has been shown to have bio-stimulatory beneficial effects on various biological processes in vitro, in vivo and also in clinical trails. We have explored the beneficial effects of light therapy (LT) on stem cells in the bone marrow in order to determine its potential application as cell therapy for the heart post myocardial infarction (MI). Preliminary results have shown that in the infarcted rat heart model the application of LT to the rat bone marrow (BM) in the hind leg 10 min and 4 hrs post MI caused a significant reduction of 79% and 75 % respectively in the scar tissue formed after MI. This is a novel, simple and non-invasive approach to improving heart function after heart attack in patients, and may also serve as a basis for cell therapy of other diseased organs. The fact that LT demonstrated efficacy in scar reduction 4 hours post MI, indicates its clinical relevance to treat patients post MI. Project ID : 2-2011-143
Universidad de Alcalá-OTRI posted this:LARES Robotic Solutions for telecareThe research group in Intelligent Systems GSI, from the Automatic Department of Alcalá University, proposes a solution for telecare and telemedicine based on a network of sensors, an autonomous robot and a health database, designed to prevent accidents of dependent people in an efficient way and offering solutions to different needs still not covered in the market. This service focuses on dependent patients and their caregivers to improve their quality of life. The system also proposes e- health databases for new medical applications with large data volumes.
Universidad de Alcalá-OTRI posted this:Walker for the mobility of people with motor disability.A research group from the Signal Theory and Communications Department of Alcalá University has developed a disability walker for improving the mobility of people with motor disability. This walker includes a guide for the leg together with an electronic system, that improves the user of manoeuvrability allowing the configuration of basic actions. This invention is part of the "Loyalty Technological Program," which has been designed by the research group to raise funds for the development and adaptation of technical aids that improve the quality of people life with motor impairments. The group is looking for collaboration agreements with institutions or companies that want to be part of the "Loyalty Technological Program" http://padrinotecnologico.org/proyectos/instituciones/ Moreover, the group is interested in reaching license, collaboration, manufacturing or commercial agreements with technical assistance with orthopaedics, medical equipment, and health technology companies. Other kind of institutions interested in sponsoring this invention are also welcome.
Universidad de Alcalá-OTRI posted this:Device and method for ventricular repolarization alternans detection by windowing.A Spanish research group from the Department of Signal Theory and Communications at University of Alcalá (Spain) has designed a device and method for detecting ventricular repolarization alternans based on continuous time analysis and the extraction of the information using windowing. As a main feature, the method presents high robustness against noise and it is very robust against variability of heart rate due to standardization techniques used. Moreover, it includes a procedure to separate the repolarization information from artifacts. Because of these characteristics, it is particularly suitable for implementation in portable monitoring devices and implantable devices. The group is looking for companies of Medical equipment and health technology to reach licensing agreements or collaboration and commercial agreements for technical assistance.